FindTrial
Sign In

Preparation of Phaltrikadi Kwath Dravya and its efficacy study on Prameha (type2 Diabetes mellitus) with evaluation of role of different Prakshepa Dravyas

Standardization of Phaltrikadi Kwath Dravya and its efficacy study on Prameha (type2 DM) with evaluation of role of different Prakshepa Dravyas - SPEPRDP

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034560
Enrollment
30
Registered
2021-07-02
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Phaltrikadi Kwath with Madhu and Haridra Churna : Phaltrikadi Kwath - 40gm With Madhu - 5gm and Haridra Churna- 10gm-OD orally for 4 weeks Control Intervention1: Phaltrikadi Kwath with

Sponsors

State Ayurvedic College and Hospital Lucknow
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1-Age group of both sex between 18-60years. 2-Patient presenting with minimum 3 chief classical signs & symptoms. 3-Fasting blood sugar range- 126mg/dl-180mg/dl (WHO) 4-Post Prandial blood sugar range- 200mg/dl-250mg/dl (WHO) 5-HbA1c � 6.5%

Exclusion criteria

Exclusion criteria: 1-Patients having age below 18 year and above 60 year. 2-Fasting blood sugar range- more than 180mg/dl 3-Post Prandial blood sugar range-more than 250mg/dl 4-Gestational diabetes 5-IDDM patient. 6-Patient suffering from any severe systemic disease. 7-Patient having other endocrine disorder. 8-Patients having diabetic complication like diabetic neuropathy, diabetic nephropathy, diabetic retinopathy. 9-HIV+ve, COVID-19 or Pregnant/lactating mother etc.

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of Phaltrikadi Kwath on Prameha (type2 DM) with evaluation of role of different Prakshepa DravyasTimepoint: To assess the efficacy of Phaltrikadi Kwath with in 4 weeks—

Secondary

MeasureTime frame
To assess the efficacy of trial drugs on subjective parameters like Prabhuta mutrata ,Avila mutrata ,Trishnadhikya ,Daurbalya ,Kshudadhikya etc. Timepoint: assessment will be done after 4 weeks of clinical trial—

Countries

India

Contacts

Public ContactDr Mandeep Jaiswal

State Ayurvedic College and Hospital, Lucknow

mandeep.ayu@gmail.com9839442777

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026